Trial Profile

Neoadjuvant chemotherapy of S-1/OXaliplatin for locally advanced Gastric cancer PI

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Jun 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
Indications Gastric cancer
Focus Adverse reactions
Acronyms Neo G-SOX PI study

Most Recent Events

17 Jun 2017 Status changed from active, no longer recruiting to completed.
02 Jun 2017 Results (n=12) of an integrated analysis on quality of life of oxaliplatin-based preoperative chemotherapy for locally advanced gastric cancer assessment from UMIN000015950 and UMIN000015181 studies, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
26 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com